WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010144734) BENZONAPHTHYRIDINE-CONTAINING VACCINES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/144734    International Application No.:    PCT/US2010/038216
Publication Date: 16.12.2010 International Filing Date: 10.06.2010
IPC:
A61K 39/39 (2006.01)
Applicants: NOVARTIS AG [CH/CH]; Lichtstrasse 35 CH-4056 Basel (CH) (For All Designated States Except US).
O'HAGAN, Derek, T. [US/US]; (US) (For US Only).
SINGH, Manmohan [US/US]; (US) (For US Only).
JAIN, Siddhartha [IN/US]; (US) (For US Only).
KOMMAREDDY, Sushma [IN/US]; (US) (For US Only)
Inventors: O'HAGAN, Derek, T.; (US).
SINGH, Manmohan; (US).
JAIN, Siddhartha; (US).
KOMMAREDDY, Sushma; (US)
Agent: Bonham, David, B.; Novartis Vaccines and Diagnostics, Inc. Corporate Intellectual Property X-100B P.O. Box Emeryville, CA 94662-8097 (US)
Priority Data:
61/185,954 10.06.2009 US
Title (EN) BENZONAPHTHYRIDINE-CONTAINING VACCINES
(FR) VACCINS CONTENANT DE LA BENZONAPHTYRIDINE
Abstract: front page image
(EN)The invention provides, inter alia, immunogenic compositions that comprise (a) a first antigen, (b) polymeric particles and (c) a benzonaphthyridine compound, which compositions elicits an immune response when administered to a vertebrate subject. The invention also provides, inter alia, methods of producing immunogenic compositions and methods for using immunogenic compositions (e.g., for treatment), among other benefits.
(FR)L'invention porte, entre autres, sur des compositions immunogènes qui comprennent (a) un premier antigène, (b) des particules polymères et (c) un composé benzonaphtyridine, lesquelles compositions déclenchent une réponse immunitaire lorsqu'elles sont administrées à un sujet vertébré. L'invention porte également, entre autres, sur des procédés de production de compositions immunogènes et sur des procédés d'utilisation de compositions immunogènes (par exemple, pour un traitement), parmi d'autres avantages.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)